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ABSTRACT 
This human-subject, mixed methods study, originally designed for six participants, was 
turned into a case study that examined the use of the Face Stimulus Assessment (FSA) with one 
individual diagnosed with early-stage dementia. The purpose of the study was to determine 
whether the participant with an early-stage dementia diagnosis could complete the FSA. 
Additionally, the Formal Elements Art Therapy Scale (FEATS) modified by Donna Betts for the 
FSA was applied to assess for applicability for individuals diagnosed with dementia. 
The results of the case study are not generalizable. However, the results from the 
individual participant were promising. The participant was able to complete the full assessment, 
and the average FEATS scores from all three stimulus drawings demonstrated that with an early-
stage dementia diagnosis, the FSA could be a good baseline assessment for tracking the 
progression of a dementia diagnosis. This case study supports continued research on the benefits 
of the FSA with this population. 
Keywords: Art therapy, Face Stimulus Assessment (FSA), dementia, early-stage 
dementia, cognitive assessments, Formal Elements Art Therapy Scale (FEATS) 
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CHAPTER I 
INTRODUCTION 
According to the World Health Organization (WHO), approximately 47 million people 
worldwide have been diagnosed with dementia (2019). WHO projects that that number will 
increase to 75 million by 2030 (2017). Additionally, by 2030, the worldwide costs for caring for 
those with dementia will rise from $818 billion in 2015 to $2 trillion (WHO, 2017).  
Pinpointing early behavior changes and cognitive decline associated with dementia can 
be crucial in predicting the projection of the disease (Iliffe, Manthorpe, & Eden, 2003). Early 
detection allows time to put community supports in place, develop care plans, and anticipate 
overall care costs necessary for a comfortable transition to life with the disease for both the 
person with dementia and their caregivers or family members (Iliffe, Manthorpe, & Eden, 2003). 
Early-stage dementia can be difficult to identify. Because there is no single test to 
diagnose dementia (Alzheimer’s Association, 2019), a battery of tools are often used, including 
psychological tests (cognitive and behavioral assessments), medical examinations and tests (i.e. 
brain scans and laboratory tests), and social measurements (activities of daily living) (Ashford et 
al., 2007). The Alzheimer’s Association (2019) reported that an accurate diagnosis of a mild 
cognitive impairment (MCI), including early-stage dementia, can potentially save Americans and 
the US government more than $7 trillion in long-term healthcare costs, further supporting the 
need for effective diagnostic tools. 
Research has shown that the benefits of art therapy for people who have been diagnosed 
with dementia include providing a vehicle for nonverbal communication, offering opportunities 
for reminiscence, enabling sensory exploration and stimulation, and engaging individuals in self-
reflective activities with a tangible end product (Kahn-Denis, 1997). Additionally, art therapy 
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can assist with diagnosis and evaluation of cognitive status (Kahn-Denis, 1997). However, to 
date, there has been no development of an art therapy-based assessment specifically used to 
assist with the diagnosis of dementia.  
The Face Stimulus Assessment (FSA) is a cognitive art therapy assessment created by 
Donna Betts in 2003 that uses stimulus imagery of a face to help determine an individual’s 
cognitive abilities. The Formal Elements Art Therapy Scale (FEATS) is a Likert-type rating 
scale that examines the relationship between the formal elements in artwork and diagnostic 
criteria (Gantt & Tabone, 1998). The FEATS was adapted by Betts to apply to the FSA for 
nonverbal autistic students (Betts, 2003). 
The purpose of the following research study was to determine whether the FSA would be 
an appropriate assessment tool for individuals with an early-stage dementia diagnosis. This 
included the ability to complete the stimulus drawings, answer questions pertaining to the 
drawings, and effectively use the materials provided. In addition to the assessment, the 
researcher reviewed the use of the modified FEATS to determine whether future modifications 
would be needed for individuals with dementia. It is the intention of the researcher that this study 
will provide preliminary support for the use of the FSA as a baseline for further, larger-scale 
research on using the FSA with this population. 
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Operational Definitions 
Art therapy: “An integrative mental health and human services profession that enriches 
the lives of individuals, families, and communities through active art-making, creative process, 
applied psychological theory, and human experience within a psychotherapeutic relationship” 
(American Art Therapy Association, 2017, para. 1). 
Dementia: “A syndrome—usually of a chronic or progressive nature—in which there is 
deterioration in cognitive function (i.e. the ability to process thought) beyond what might be 
expected from normal ageing. It affects memory, thinking, orientation, comprehension, 
calculation, learning capacity, language, and judgement. Consciousness is not affected. The 
impairment in cognitive function is commonly accompanied, and occasionally preceded, by 
deterioration in emotional control, social behavior, or motivation” (World Health Organization 
[WHO], 2019, para. 1) 
Early-stage dementia: A diagnosis characterized by symptoms such as issues with 
memory, language, speed of thought, and behavior that begin to affect an individual’s everyday 
life. Those with early-stage dementia are able to be fairly independent (Alzheimer’s Association, 
2019a). 
Face Stimulus Assessment (FSA): A three-part art therapy assessment that uses stimuli 
images to assess cognitive functioning (Betts, 2003). 
Formal Elements Art Therapy Scale (FEATS): A 0–5 Likert rating scale system that 
measures 14 specific global variables in 2D artwork (Gantt, 2016). These variables are 
prominence of color, color fit, implied energy, space, integration, logic, realism, problem 
solving, developmental level, details of objects and environment, line quality, person, rotation, 
and perseveration. 
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Modified Formal Elements Art Therapy Scale (FEATS): A modified version of the 
FEATS. The modified FEATS was developed to apply to the FSA. It includes the following 
components: prominence of color, color fit, implied energy logic, realism, developmental level, 
details of objects and environment, line quality, and perseveration (Betts, 2003). 
Executive functioning: The high-level cognitive thinking used to control and coordinate 
other cognitive abilities, such as organizing information (e.g. attention, planning, sequencing, 
problem-solving, working memory, cognitive flexibility, abstract thinking, rule acquisition, 
selecting relevant sensory information) and regulating that information in response to the 
environment (initiation of action, self-control, emotional regulation, monitoring internal and 
external stimuli, initiating and inhibiting context-specific behavior, moral reasoning, decision-
making) (University of California, San Francisco: Memory and Aging Center [UCSF], 2020). 
Abstract thinking: Described by Dumontheil (2014) as follows: “Thoughts can be 
temporally abstract and relate to long term goals, or past or future events, or relationally abstract 
and focus on the relationships between representations rather than simple stimulus features” (p. 
58). 
Visuospatial functioning: The ability to determine and identify where an object or 
stimulus is in space (Quental et al., 2013). 
Graphic indicator: In a review of research, no single definition of graphic indicators 
was found. For the purposes of this thesis, a graphic indicator is defined as a common, 
identifiable, and consistent drawn characteristic or element in artwork. This definition is based 
on research by Gantt and Tabone (1998) on global characteristics (p. 23). 
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CHAPTER II  
LITERATURE REVIEW 
Dementia is known as a syndrome associated with memory loss. However, it is far more 
complex and integrated than simply having issues with memory. Dementia is an umbrella term 
used to describe chronic and progressive brain deterioration that causes disturbances in higher 
cortical functioning affecting memory, judgment, comprehension, language, motivation, 
orientation, and self-regulation (Broderick & Blewitt, 2015, p. 561; Nuffield Council on 
Bioethics, 2009; World Health Organization [WHO], 2012). 
Types of Dementia 
There are many different types of dementia, including Alzheimer’s disease, vascular 
dementia, frontotemporal dementia, Lewy Body dementia, Parkinson’s disease, and mixed 
dementia (Alzheimer’s Association, 2019b). Of these, Alzheimer’s disease is the most common. 
Although each dementia type is different, there is no cure for any diagnosis of dementia. Every 
type of dementia is pervasive and chronic, worsens over time, and is irreversible (Sahyouni, 
Varma, & Chen, 2017, p. 60). 
Alzheimer’s disease. During the progression of Alzheimer’s disease (AD), excessive 
protein fragments (beta-amyloid, or plaques) accumulate on outer areas of neurons in the brain 
and twisted strands of protein (tau, or tangles) collect inside neurons in the brain (Alzheimer’s 
Association, 2018a; Alzheimer’s Society, 2017; Nuffield Council on Bioethics, 2009). Over 
time, the buildup of these proteins block chemical connections between neurons, causing the 
neurons to die (Alzheimer’s Society, 2017). Protein accumulation typical of AD occurs years 
before any symptoms of the disease arise, which is why AD is considered a slow progressive 
brain disease (Alzheimer’s Association, 2018a). 
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Early symptomology of AD includes difficulty remembering recent conversations, 
names, or events; apathy; depression (Alzheimer’s Association, 2018a); and issues with abstract 
thinking, and with executive and visuospatial functioning (Quental et al., 2013). As AD 
progresses, symptoms include “impaired communication, disorientation, confusion, poor 
judgment, behavioral changes, and ultimately difficulty speaking, swallowing and walking” 
(Alzheimer’s Association, 2018a, p. 369).  
Historically, an AD diagnosis—elevated levels of beta-amyloid and tau in the brain—
could be confirmed only after a postmortem examination (Alzheimer’s Association, 2018a). 
However, a 2011 study published by the National Institute on Aging found that the biomarkers 
present postmortem can also be detected in live subjects through the use of positron emission 
tomography (PET) imaging and cerebrospinal fluid (CSF) tests (Alzheimer’s Association, 
2018a). An informed diagnosis of dementia requires multiple components of a large-scale 
assessment. 
Vascular dementia. Vascular dementia (VD) occurs as a result of blood vessel 
blockages within the brain. These blockages generate a lack of oxygen supply, causing the death 
of brain cells and tissue and/or brain bleeding (Alzheimer’s Association, 2018a; Alzheimer’s 
Society, 2017; Nuffield Council on Bioethics, 2009, p. 5). VD is most common with individuals 
who have experienced a stroke or a series of small strokes. The area of the brain damaged due to 
an interruption in blood supply or stroke determines what type of VD is present. There are two 
types: single-infarct VD and multi-infarct VD. Single-infarct VD is a result of one large stroke 
affecting one single and sometimes large area of the brain. With single-infarct VD, symptoms are 
noticeable directly after the stroke (Nuffield Council on Bioethics, 2009). In contrast, multi-
infarct VD is due to multiple smaller strokes occurring over time that affect many different areas 
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of the brain. With multi-infarct VD, symptoms are more gradual and worsen over time (Nuffield 
Council on Bioethics, 2009). VD’s early symptoms include “impaired judgment or impaired 
ability to make decisions, plan or organize” (Alzheimer’s Association, 2018a, p. 369). This 
differs from the memory loss symptomatic of AD. 
Frontotemporal dementia. Frontotemporal dementia (FTD) is caused by damage to or 
deterioration in the frontal or temporal lobes in the brain (Nuffield Council on Bioethics, 2009, p. 
5). When FTD is present, the affected lobe becomes atrophied and the upper layers of the 
cerebral cortex become soft and spongy (Alzheimer’s Association, 2018a). FTD has little to no 
effects on a person’s memory. Instead, it affects the ability to communicate through language, 
speech, and behavior (Alzheimer’s Association, 2018a). The three different clinical forms of 
FTD are behavioral variant FTD, temporal variant (semantic) dementia, and progressive 
nonfluent aphasia (Fymat, 2018). Behavioral variant FTD is the most common of the three and 
results in changes to a person’s personality and behavior. Symptoms of temporal variant 
(semantic) dementia include issues with producing and/or comprehending language (Alzheimer’s 
Association, 2018a). Progressive nonfluent aphasia is present when a person gradually loses the 
ability to communicate verbally, leaving the person mute (Fymat, 2018). According to the 
Alzheimer’s Association (2018a), 60 percent of people diagnosed with FTD are between 45 and 
60 years old. 
Lewy body disease. Dementia with Lewy body (DLB) is a result of abnormal clumps 
(Lewy bodies) of a spherical protein called alpha-synuclein (Alzheimer’s Association, 2018a). A 
buildup of these clumps in neurons causes chemical imbalances and disruptions in normal neural 
transmission functions in the brain (Nuffield Council on Bioethics, 2009). While many 
symptoms of DLB are similar to AD, the following are unique to DLB: sleep disturbances, visual 
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hallucinations, attention disorientation, executive functioning difficulties, and motor functioning 
similar to Parkinson’s disease (PD) (Alzheimer’s Association, 2018a). 
Parkinson’s disease and mixed dementia. The aggregations of Lewy bodies that are 
responsible for DLB are also present for those with Parkinson’s disease (PD). With DLB, Lewy 
bodies develop in the cerebral cortex, causing cognitive impairment. In contrast, with PD, Lewy 
bodies develop in the substantia nigra, affecting motor functioning (Alzheimer’s Association, 
2018a). As PD progresses, it often results in AD or DLB as a secondary dementia. A pathology 
with multiple dementia diagnoses is referred to as mixed dementia. According to the Alzheimer’s 
Association (2018a), mixed dementia is more common than previously reported. Newer studies 
suggest 50 percent of people diagnosed with a specific type of dementia may eventually present 
with symptoms of more than one specific type of dementia (Alzheimer’s Association, 2018a). 
Dementia Diagnosis 
Diagnosing dementia is complex, time-consuming, and sometimes expensive. Dementia 
is split into three primary stages: early-, middle-, and late-stage dementia (Dementia Care 
Central, 2018; WHO 2017). 
As noted, there is no single diagnostic tool for dementia. When assessing an individual 
for dementia, many components are reviewed to ensure an accurate diagnosis. Physicians, with 
the help of specialists such as geriatricians, geriatric psychiatrists, and neurologists, can diagnose 
a person with dementia by having extensive conversations with family members or caregivers 
regarding changes in psychosocial functioning, performing medical examinations, and 
administering cognitive assessments. The following sections provide an overview of the variety 
of assessment measures used for diagnosing dementia. 
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Psychosocial functioning. An assessment of psychosocial functioning is usually 
conducted with the immediate family by a geriatrician. During the assessment, the geriatrician 
enquires about mood and behavioral changes, family medical history, psychiatric history, and 
current and past illnesses (Alzheimer’s Association, 2020). This is done primarily because family 
members and caregivers are more likely to notice changes in the individual before the individual 
is assessed (Bunn et at., 2012). This process also provides the geriatrician and other healthcare 
providers with an understanding of existing support systems and an opportunity to discuss 
available support options after a diagnosis has been made (Bunn et al., 2012). The psychosocial 
functioning assessment enables the geriatrician to rule out other mental health issues that could 
be presenting with similar symptomologies (Alzheimer’s Association, 2018a). 
Medical examinations. Medical examinations are conducted by a geriatrician to rule out 
other health issues that present with dementia-like symptoms, such as depression, untreated sleep 
apnea, delirium, side effects of medications, thyroid problems, certain vitamin deficiencies, and 
excessive alcohol consumption (Alzheimer’s Association, 2020). The geriatrician will also assess 
for signs of strokes that can lead to VD (Stanford Health Care, 2020c).  
Brain image scans may be conducted to detect underlying issues that cause dementia or to 
rule out other issues that could be causing dementia-like symptoms (Alzheimer’s Association, 
2020; Stanford Health Care, 2020a). Types of image scans used to detect dementia include 
computed tomographic (CT) scans and magnetic resonance imaging (MRI) scans (Alzheimer’s 
Association, 2020; Stanford Health Care, 2020a). CT scans can be used to detect evidence of 
brain atrophy, strokes, and changes in blood vessels. MRIs can be used to detect the same issues 
as a CT scan, but are better at detecting brain atrophy and brain damage from smaller strokes 
(Alzheimer’s Association, 2020; Stanford Health Care, 2020a). A third type of image scan is a 
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positron emission tomography (PET) scan. PET scans can be used detect changes in glucose 
metabolism, the presence of beta-amyloid proteins in the brain, and problems with blood flow 
(Stanford Health Care, 2020a). However, PET scans that detect tau proteins in the brain are 
currently available only through research studies (Stanford Health Care, 2020a). 
Laboratory tests are another type of medical examination that geriatricians use to rule out 
other health conditions, such as a hormone imbalance (Stanford Health Care, 2020b). These lab 
tests include “complete blood count, blood glucose test, urinalysis, drug and alcohol screenings, 
cerebrospinal fluid analysis (to rule out specific infections that can affect the brain), and analysis 
of thyroid and thyroid-stimulating hormone levels” (Stanford Health Care, 2020b, para. 1). 
Cognitive assessments. According to Stanford Heath Care (2020c), cognitive 
assessments measure “memory, language skills, math skills, visual and spatial skills, and other 
abilities related to mental functioning to help them diagnose a patient’s condition accurately” 
(para. 1). The most common cognitive assessments include the Mini-Mental State Examination 
(MMSE) and the Montreal Cognitive Assessment (MoCA). The MMSE is a cognitive 
functioning tool used to assess orientation, registration, attention and calculation, recall, 
language, repetition, reading, writing, comprehension of commands, and drawing (Carnero-
Pardo, 2013). The exam takes approximately 7–10 minutes and scores range between 0 and 30. 
A score between 20 and 24 on the MMSE suggests signs of early-stage dementia, a score 
between 13 and 20 suggests middle-stage dementia, and anything lower than 12 indicates late-
stage dementia (Alzheimer’s Association, 2020). The MoCA is a 30-question tool that offers the 
ability to accurately detect MCI and early-stage dementia (Fymat, 2018; Pinto et al., 2019). 
Unlike the MMSE, the MoCA can be used to test executive functioning, higher-level language 
abilities, and complex visuospatial processing (Nasreddine et al., 2005). 
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The clock drawing test (CDT) is a widely used screening tool for dementia. Accurately 
completing the test requires auditory and visual comprehension, concentration, visuospatial 
abilities, abstract thinking, and executive control (Cacho et al., 2010; Wang et al., 2014). CDT 
scores correlate with MMSE scores; however, according to Wang et al. (2014), there are 11 
different scoring systems and processes for administration and scoring the CDT. The most 
common administration is to ask the individual to add numbers and hands to a pre-drawn circle 
to resemble a clock set to a specific time (Cacho et al., 2010). The CDT is easy and fast to 
administer, has less educational bias than the MMSE, is suitable for non–English speaking 
individuals, and allows for the evaluation of multiple cognitive domains (Cacho et al., 2010; Nair 
et al., 2010). 
An additional tool used by geriatricians is the Functional Staging Assessment Test 
(FAST). Like the GDS, the FAST has seven stages, but instead of testing for cognitive 
functioning, it assesses the level of functioning in daily activities (Dementia Care Central, 2018). 
It is possible for a person to be at a different cognitive stage on the GDS than functioning on the 
FAST (Dementia Care Central, 2018). The FAST scale is often given to family members or care 
takers of individuals presenting with dementia. The stages of dementia are explained next. 
Stages of dementia. The foundation for the three stages of a dementia diagnosis (early-, 
middle-, and late-stage) derives from a seven sub-stage assessment: The Global Deterioration 
Scale (GDS), also called the Reisberg Scale. The GDS is a standardized tool used to assess and 
track symptomology and treatment needs as the disease progresses. The GDS is primarily used to 
assess symptoms of AD. However, it can be used to assess the stage progression for other types 
of dementia (Dementia Care Central, 2018). The stages of the GDS are described here. 
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Stage 1 and 2. In stage 1, a person functions with no signs of cognitive decline or signs 
of memory deficit (Reisberg, Ferris, De Leon, & Crook, 1982). In stage 2, an individual presents 
with forgetfulness that is common with the “normal” aging process (Dementia Care Central, 
2018; Reisberg et al., 1982). Stages 1 and 2 on the GDS typically do not exhibit enough 
symptomology for a dementia diagnosis (Dementia Care Central, 2018; Reisberg et al., 1982). 
Stage 3. Stage 3 is classified as MCI; where the earliest and clear signs of memory 
deficits become apparent (Reisberg et al., 1982). However, this stage is difficult to diagnose 
because symptomologies do not disrupt day-to-day functioning or abilities (Alzheimer’s 
Association, 2019a). MCI can either develop into a form of dementia, remain stagnant, or even 
improve with cognitive performance (Mitchell & Shiri-Feshki, 2009). Intensive interviews 
conducted by geriatric psychiatrists are used to identify difficulties in concentration, difficulties 
in performance at work and around people, and observable behaviors (e.g. losing keys or objects 
of importance, forgetting names, and/or having difficulty finding words) (Reisberg et al., 1982). 
It is common for individuals to experience mild to moderate anxiety in this stage due to coping 
with the changes and challenges they are experiencing in the workplace and in social settings 
(Reisberg et al., 1982). 
Stage 4. In this stage, the differentiation between MCI and an early-stage dementia 
diagnosis is present. Therefore, stage 4 is considered early-stage dementia. Symptomology 
including cognitive decline is apparent and evident in both clinical testing and interviews. 
Symptoms such as the following are also noted in this stage: deficits in short-term memory, 
decreased knowledge or confusion in life stories or personal events, difficulty or changes in 
concentration and executive functioning, changes in behavior and/or personality (i.e. depression, 
apathy, wandering, sleep disturbances, agitation, and aggression), and an inability to travel alone, 
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manage personal finances, engage socially, and perform complex tasks accurately and efficiently 
(Alzheimer’s Association, 2018b; Fymat, 2018; Reisberg et al., 1982). Vocabulary retrieval, 
verbal fluency, and comprehension of higher-order written and spoken languages also become 
impaired in the early stages of AD (Ferris and Farlow, 2013). 
Some individuals present with denial as a defense mechanism for the overwhelming loss 
and recognition of their cognitive decline (Reisberg et al., 1982). Even though decline is 
inescapable at this stage, individuals still have the ability to recognize familiar faces and orient 
themselves in time and space (Reisberg et al., 1982). According to the GDS, by the time 
symptoms of cognitive decline or behavioral changes are present and noticeable, a person has 
met the criteria for stage 4 (Dementia Care Central, 2018; Reisberg et al., 1982). 
Stage 5. Stage 5 is characterized by moderate cognitive decline and marks the beginning 
phase of a middle-stage dementia diagnosis. The middle stage is the longest stage in the 
progression of the disease, lasting for many years (Alzheimer’s Association, 2018b). During this 
stage, the level of care for an individual increases (Alzheimer’s Association, 2018b) due to 
symptoms like disorientation with time and space, decline in attention to daily living skills like 
selecting appropriate clothing and personal hygiene, forgetting names of friends and colleagues, 
difficulty with addresses and telephone numbers, and difficulty completing simple daily tasks 
(Alzheimer’s Association, 2018b; Reisberg et al., 1982). 
Stage 6. Like stage 5, stage 6 is classified as middle-stage dementia. Individuals in the 
sixth stage lose almost all ability to care for themselves, require extensive assistance with daily 
activities, and experience continuous decline in short-term and long-term memory (Alzheimer’s 
Association, 2018b; Fymat, 2018; Reisberg et al., 1982). Older adults in this stage often 
experience changes in sleep patterns, spatial orientation (e.g. wandering or becoming lost), and 
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significant emotional and behavioral changes, such as suspiciousness, delusions, and repetitive 
and/or compulsive behaviors (Alzheimer’s Association, 2018b; Reisberg et al., 1982). Anxiety 
tends to increase, causing agitation and sometimes violent behaviors, as well as cognitive abulia, 
or a “loss of willpower that occurs because an individual cannot carry a thought long enough to 
determine a purposeful course of action” (Reisberg et al., 1982, p. 1137). 
Stage 7. When an individual has reached terminal and late-stage dementia—stage 7—
verbal abilities and communication are severely impaired. By this stage, the individual has lost 
the ability to respond to their environment, carry on conversations, eat on their own, support their 
head, and communicate facial expressions (Alzheimer’s Association, 2018b). Eventually, their 
reflexes become abnormal, muscles become rigid, and they have difficulty swallowing (Reisberg 
et al., 1982). Care for older adults at this stage include hospice as well as engaging in calming 
care such as listening to relaxing music and offering reassuring touch (Alzheimer’s Association, 
2018b). 
Dementia and Art 
Making art and engaging in the creative process can be effective with older adults who 
have dementia in assisting with the evaluation of cognitive functioning, diagnoses (Kahn-Dennis, 
1997), and rehabilitation strategies (Palmiero et al., 2012). More recently, there has been a spike 
in research regarding the evaluation of creativity and its relationship with brain deterioration 
present in dementia (Palmiero et al., 2012). Studies with professional artists diagnosed with 
dementia have demonstrated an ability to track the progression of the disease (Kahn-Denis, 1997; 
Stewart, 2004)—although research on the use of artmaking as a means to track the progression of 
the disease in non-artists appears to be lacking. 
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Stewart (2004) found patients with an early-stage dementia diagnosis had the ability to 
use color appropriately, include depth and proportion, and render a high level of detail in their 
artwork. Three-quarters of individuals with middle-stage dementia were able to use color in a 
“somewhat” appropriate fashion and attempted to generate representational forms and shapes 
(Stewart, 2004). However, individuals in late stage dementia were capable of making art using 
only scribbles, and color was not used representationally (Stewart, 2004). 
Palmiero et al. (2012) conducted an analysis of literature and found that patients 
diagnosed with AD or FTD showed a decrease in creativity over time. Researchers have noted 
that the progression of artwork of individuals with AD is parallel to the progression of the 
disease, with the artwork becoming more abstract and simple, reflecting a more restricted color 
palette, and being characterized by increasingly distorted perspective and changes in 
visuospatial/constructive organization (Mendez, 2004; Palmiero et al., 2012; Safar & Press, 
2011). Maurer and Prvulovic (2004) found that when an AD diagnosis involved damage to 
visuospatial functioning in the brain, common graphic indicators in artwork consisted of “fewer 
angles, impairment of both depth perception and spatial relations, and oversimplification” (p. 
236). In contrast, artwork by those with FTD presents characteristics of bizarreness, 
disinhibition, and alterations in social behaviors and personality, but visuospatial abilities and 
perceptual and motor planning skills remain evident (Palmiero et al., 2012). 
Kahn-Denis (1997) reported consistent and common graphic changes in artwork for those 
with dementia, including the presence of short and scattered lines, perseveration (i.e. repetition 
of lines, symbols, or shapes), a small and cramped appearance, and overlapping configurations. 
Additionally, fragmentation, perceptual rotation, and confused perspective, disconnections, and 
interruptions in the process of drawing were observed. Finally, omissions of essential features in 
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artwork causing an impoverished appearance was reported, as was difficulty following or 
comprehending directions Kahn-Denis, 1997). 
Stewart (2004) stated that artwork—when viewed over time—has the ability to track the 
progression of dementia. Although it is difficult to assess the production and meaning behind 
works of art made by individuals with dementia, it is possible to analyze artwork with objective 
assessments (Palmiero et al., 2012) such as cognitive art therapy assessments because of their 
focus on consistent graphic indicators that can be tracked over time. 
Art Therapy Assessments 
Drawings add an additional element of communication, serve as a bridge between the 
client and therapist, and can be a primary source for measuring a person’s current level of 
functioning (Oster, 2004). Although anthropologists, educators, psychologists, and psychiatrists 
have been using art in therapy since 1887, it was not until the 1950s that art therapists began 
using and exploring ways in which art-based assessments could be standardized (Betts, 2016). 
Art therapists use two general types of art-based assessments: informal and formal. 
Informal assessments include clinical interviews or observational sessions, while formal 
assessments include standardized materials, rating systems, and procedures (Deaver, 2016).  
The use of projective drawing assessments in art therapy has been widely debated, 
primarily because studies yield mixed results. However, Gantt (2004) explained that assessments 
that yield research are a fundamental requirement for all developing and existing professions, 
noting that: 
…demands for objectivity and a sound scientific basis apply to social work, medicine, 
counseling, and the other creative arts therapies. It is imperative to show the efficacy of 
one’s interventions or treatments… (p. 19). 
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Art-based assessments are often used by art therapists as a tool for client evaluation to 
determine their level of functioning, formulate treatment objectives, assess strengths, gain an 
understanding of the presenting problems, and evaluate progress over time (Betts, 2006). There 
is no single art-therapy assessment that works for all clients in all settings; therefore, assessments 
should be selected for a client’s specific needs (Betts, 2013a). In 2013, Betts organized and 
described four domains of art-therapy assessments: clinical interview, assessment of relationship 
dynamics, cognitive/neuropsychological and developmental evaluation, and tools that address 
various realms of treatment (Betts, 2013a). 
Universal terminology is essentially to building the foundation of understanding needed 
to interpret and analyze art therapy assessments. Barnet (2011) calls formal analysis “the result 
of looking closely—[it] is an analysis of the form the artist produces; that is an analysis of the 
work of art, which is made up of things such as line, shape, color, texture, mass, composition” (p. 
46). Formal analysis is not based on opinions, but rather on observations by the viewer. It is 
composed of two subcategories: formal elements and principles of design. Formal elements—
line, shape, color, form, texture, and space—are described as the components that make up the 
artwork, can be isolated and defined, and are observable (Getlein, 2004). Principles of design—
unity, balance, repetition, pattern, emphasis, proportion, movement, variety, and rhythm—are 
ways in which artists use the formal elements in decision-making when creating artwork 
(Getlein, 2004; Getty, 2011a). Formal elements and principles of design are not just the language 
in which art is understood and interpreted; they are also instinctual—a natural part of human 
perception. Artists usually become more aware of them as they are trained to understand how 
they are used and observed in artmaking (Getlein, 2004; Getty, 2011b). 
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Because formal analysis uses a formalized language to describe elements in artwork and 
is based on the observation of artwork and not on opinions, it can be used with quantitative 
variables (Pénzes et al., 2018). Art therapists can observe formal elements to formulate a 
perspective on an individual’s level of functioning as well as their strengths and weaknesses to 
support a descriptive diagnosis (Pénzes et al., 2018). 
The Formal Elements Art Therapy Scale (FEATS) 
The Formal Elements Art Therapy Scale (FEATS) was created by Linda Gantt and 
Carmello Tabone in 1990 to measure specific global variables that were hypothesized to be the 
graphic equivalents of psychiatric symptoms (Gantt & Tabone, 1998). Gantt and Tabone used 
diagnostic criteria from the Diagnostic and Statistical Manual of Mental Disorders, Third 
Edition (DSM III) as well as drawings created over the course of several decades to correlate a 
specific diagnosis with characteristics found in artwork (Gantt, 2016). 
The FEATS is a 0–5 Likert-type rating scale that provides quantitative and standardized 
measuring variables on drawn imagery. The FEATS was originally created for an art therapy 
assessment called Person Picking an Apple from a Tree (PPAT; Gantt, 2016). This assessment 
supported the development of the FEATS because the content of the drawing is both consistent 
and ideal for researching differing characteristics in drawings for various groups of people (Gantt 
& Tabone, 1998). Gantt and Tabone wanted to see “what diagnostic information drawings 
conveyed without any additional information from or about the artist” (Gantt, 2016, p. 54). They 
also wanted to prove that diagnostic information was embedded not only in what the artwork is 
about, but also in how the artwork is done (Gantt and Tabone, 1998). The FEATS was developed 
and remains an important rating tools for art therapists because it focuses on the process and 
product of the artwork and not the individual. The manual created to accompany the FEATS 
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provides rating samples, directions, and an alignment guide for diagnostic criteria as they relate 
to the rating of the artwork.  
The research conducted by Gantt and Tabone suggested that formal elements of art 
translate to psychiatric symptomology and that the following 14 variables (or elements) may 
correlate with changing symptoms of a diagnosis (Stewart, 2004). The following overview 
provides an understanding of how each variable is defined and interpreted with regard to the 
PPAT drawing. 
Prominence of color. Measures the way in which the individual uses color throughout 
the entire drawing (Gantt, 2009; Gantt & Tabone, 1998). Gantt and Tabone (1998) stated that 
color is related to affect and that color has an emotional impact. 
Color fit. Measures how conventional or realistic color choices are in the face and 
surrounding imagery (Gantt, 2009; Gantt & Tabone, 1998). 
Implied energy. Measures the amount of effort the rater believes it took for the 
participant to complete the drawing (Gantt, 2009; Gantt & Tabone, 1998). 
Space. Refers to and measures the amount of space filled and used for the drawing 
(Gantt, 2009; Gantt & Tabone, 1998) 
Integration. Understood as whether or not the subjects and elements within the drawing 
are related to each other, balanced, and cohesive (Gantt, 2009; Gantt & Tabone, 1998). 
Logic. Relates to whether bizarre or irrational elements that are not a part of the 
requested response of the assessment appear within the drawing (Gantt, 2009; Gantt & Tabone, 
1998). It can also show impairment in abstract thinking (Gantt & Tabone, 1998). 
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Realism. Relates to how recognizable all the elements are in the drawing. The more 
realistic and three dimensional the drawing appears to be, the higher the rating (Betts, 2013b; 
Gantt, 2009; Gantt & Tabone, 1998). 
Problem solving. Measures whether or not the individual drew a person picking an apple 
from a tree and how they accomplished this task (Gantt, 2009; Gantt & Tabone, 1998). 
Developmental level. Developed from Viktor Lowenfeld’s stages of artistic development 
(Betts, 2013b; Gantt, 2009; Gantt & Tabone, 1998). The five stages are scribbling, preschematic, 
schematic, dawning realism, and pseudo-naturalistic (Lowenfeld & Brittain, 1987). These 
developmental levels are aligned with the chronological age in which the individual would have 
mastered the tasks of that stage. 
Details of objects and environment. Identifies objects depicted in the drawing and any 
additional features to the figure and objects in the final image (Betts, 2013b; Gantt, 2009; Gantt 
& Tabone, 1998). 
Line quality. Identifies how much control the participant exhibited when drawing the 
lines in the image (Betts, 2013b; Gantt, 2009; Gantt & Tabone, 1998). 
Person. Measures the individual’s ability to draw a person either as a stick figure or a 
three-dimensional form (Gantt & Tabone, 1998). Fragmentation or distortion of the human figure 
in the drawing are found in several psychiatric disorders (Gantt & Tabone, 1998). 
Rotation. Measures the amount of tilt or rotation objects drawn in the image display in 
relation to the plane, horizon, or ground on which they rest (Gantt, 2009; Gantt & Tabone, 1998). 
Perseveration. Describes the repetition of lines, forms, and/or shapes. Perseveration is 
explained as a “repeated motor act such as making a short line over and over without seeming to 
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be aware of doing so” (Gantt, 2009, p. 128). Perseveration can be found in artwork created by 
those who have conditions affecting the frontal lobe, like AD (Gantt & Tabone, 1998). 
Since the development of the FEATS in 1990, it has been recommended that future 
research be conducted with larger-scale normative studies, studies with distinct populations, and 
the alignment of the FEATS with other drawing assessments to further enhance the 
understanding and applicability of this rating tool (Gantt, 2016). Studies that inform specific 
clusters or patterns in scores (high scores on certain variables and low scores on other variables) 
that best describe artist changes indicative of certain diagnoses are also called for (Gantt, 2001; 
Gannt & Tabone, 1998). For example, individuals with major depressive disorder have clusters 
or patterns of low scores with the prominence of color, space, and implied energy variables and 
high scores on the logic variable (Gantt, 2001). In Gantt and Tabone’s research during the 
development of the FEATS, “considerable differences were seen if drawings were collected 
before and after a person received psychotropic medication” (Gantt, 2016, p. 571). This allows 
for the assumption that artwork has the ability to track psychological states and treatment 
progress. 
The FEATS is a versatile rating tool that can be applied to many different drawing 
assessments, allowing for artwork to be formally assessed and tested with various populations. 
Face Stimulus Assessment (FSA) 
The Face Stimulus Assessment (FSA) was created to help clinicians better understand the 
cognitive, developmental, and creative potentials of children, adolescents, and adults (Betts, 
2003; Mattson & Betts, 2016), with a specific focus on the cognition of nonverbal autistic 
students (Betts, 2003).The FSA involves the presentation of three consecutive stimulus drawings. 
The first stimulus drawing is of a face, including the outline of a head, shoulders, eyes, nose, 
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ears, mouth, and eyebrows. The second stimulus drawing is an outline of the head and shoulders. 
The third drawing is a blank sheet of paper. Ideally, giving a participant two consecutive 
opportunities to organize facial elements on the first two stimulus drawings presents an 
opportunity to show memory and visual retention in the third image (Betts, 2003). According to 
Mattson and Betts (2016): 
The theoretical basis of stimulus drawings relies heavily on behavioral fading, in which a 
participant received fewer cues with each successive drawing. The participant then 
responds to the final stimulus without referring to the previous drawings, with the 
intention that the participant learned the faded cues (p. 580). 
The FSA can reveal a person’s capacity for visual retention, memory, and arrangement, 
as the images are given in succession to one another. 
The FSA uses a modified version of the FEATS to rate only the second picture. The 
modified FEATS includes nine of the original 14 variable scales: prominence of color, color fit, 
implied energy, logic, realism, developmental level, details of objects and environment, line 
quality, and perseveration (Betts, 2013b). Mattson and Betts (2003) explain that only the second 
image is to be rated using the modified FEATS because the nine scales are more relevant for this 
drawing. The second drawing provides the least amount of stimulus, which allows for the best 
determination in developmental level and cognitive skills (Mattson & Betts, 2003). 
For the facial features in drawing 1, steps were taken to create a stimulus image that was 
culturally inclusive (Betts, 2003). Betts (2003) stated, “The making of a face stimulus that was 
gender neutral, nonspecific as to age, and representative of a variety of cultures was a difficult 
task” (p. 78).  
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The decision to use a face as the stimulus image relates to the fact that in early infancy, 
babies are attracted to human faces, and have the ability to maintain their attention when looking 
at a face (Betts, 2003). The face is also the main region of the body that is directly correlated 
with expressions of emotion and aesthetic judgement (Betts, 2003). For Betts, working with 
individuals and face stimulus imagery raised a lot of observations pertaining to an individual’s 
capacity for memory, perception, and cognitive abilities (Betts, 2003). 
Limited research has been conducted on the use of the FSA with those diagnosed with 
dementia. Kim and Betts (2016) conducted a correlational study of the FSA and the clock-
drawing test (CDT) to see if the FSA could be used as a diagnostic tool. The study did not use 
the modified FEATS Betts created with the FSA as the rating instrument. Instead, it used a rating 
system developed by Kim in 2010 (Kim & Betts, 2016). The results indicated that the FSA could 
be used as a diagnostic tool to screen for dementia (Kim & Betts, 2016). 
This promising study demonstrates the need for continued research in the connection 
between dementia and art therapy assessments, specifically in the effectiveness of the FSA as an 
assessment tool for individuals with dementia. 
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CHAPTER III  
METHOD 
Design of Study 
In this pilot, mixed-methods study, the FSA was administered with an individual with an 
early-stage dementia diagnosis. A pilot study is a small-scale study conducted to evaluate 
whether a large-scale study might be called for in the future. The quantitative portion of this 
study included the modified FEATS rating scale for the FSA and the researcher developed 
additional FSA observation form. The purpose of the study was to determine whether 
participants with an early-stage dementia diagnosis could complete the FSA. Additionally, the 
study sought to assess the applicability of the FSA (and the modified FEATS) and whether it 
would need to be modified for use with individuals diagnosed with dementia. At the time of the 
study, there was no published research on the use of the FSA and modified FEATS with 
individuals diagnosed with dementia. 
Location and Time Period of Study 
The study was conducted at a geriatric center that was a part of a large, metropolitan 
hospital. A geriatric center is a specialty unit attached to a large-scale hospital that specializes in 
the health of older adults. The full study took place from January 2020 through March 2020. The 
signing of consent forms and the administration of the FSA were held in a private conference 
room at the geriatric center. Consent signage and administration happened in the same session 
(see Appendix A and Appendix B). A time frame of 2.5 hours was allotted for consent signage 
and FSA administration. This included 30 minutes for consent review, 30 minutes for questions, 
60 minutes for FSA administration, and 30 minutes to fill out the participant inquiry form. The 
study was approved by both the hospital and university’s Institutional Review Board (IRB). 
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Subject Type and Source 
Participants were patients of the geriatric center. The study was designed for six 
participants with an early-stage dementia diagnosis. 
Enrollment, Recruitment, Inclusion, and Exclusion Criteria 
The principal investigator and researcher worked with personnel at the supporting 
research facility to screen for participants to use in the study. Subjects were recruited by social 
workers at the geriatric center. Subjects who were interested in participating in the study were 
then contacted via phone by the researcher to schedule a time and date for administration of the 
FSA and to address questions. 
The inclusion criteria were an early-stage dementia diagnosis. Exclusion criteria included 
severe vision impairment or blindness (because of the nature of the scoring criteria for the FSA). 
Parkinson tremors were also considered an exclusion because they may lead to specific outliers 
for the perseveration section of the modified FEATS. Finally, participants who were not 
proficient in the English language were excluded due to limitations when answering questions on 
the participant inquiry form. 
Investigational Methods and Procedures 
Informed consent. Before administering the FSA, the researcher met with each 
participant and their legally authorized representative (LAR) to review and sign consent forms 
and to answer questions posed by the participant or LAR with regard to the study. The researcher 
also verbally reviewed the following consent items: study withdrawal, assessment length, and 
confidentiality. After the consent form was signed by both the participant and the LAR, the FSA 
was administered, and the participant inquiry form was addressed. 
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Instrumentation. The FSA is a copyrighted assessment, including the directions for the 
materials, administration, and evaluation (Betts, 2013b). 
Materials were organized before the start of the assessment and included the FSA 
stimulus drawings and one pack of eight multicultural markers (that is, markers that reflect a 
variety of skin tones) and one pack of eight colored markers. The markers were mixed together 
and placed on the table to the right of the participant’s seat. After the consent form was reviewed 
and signed by both the participant and the LAR, the LAR was asked to leave the room to avoid 
distracting the participant or assisting them with the assessment. The researcher administered the 
FSA. The FSA has a time limit of 60 minutes. Afterward the researcher and the participant went 
over the FSA participant inquiry form per the manual instructions. 
The researcher used an FSA observation form (Appendix C) created to track the 
following behavioral observations: participant’s ability to complete the FSA, recorded time of 
completion, redirection, fine and gross motor skills ability, and any other notable verbalizations 
or behaviors. The development of this form was informed by the research of Denis-Kahn (1997) 
and symptomology of dementia presented by the Alzheimer’s Association (2018a; 2018b; 
Fymat, 2018; Reisberg et al., 1982). 
The ability to complete the FSA was scored on a yes or no scale based on the completion 
of the FSA in the allotted 60-minute time frame. If the participant did not draw a face for the 
second drawing in the assessment, it was recorded as an incomplete assessment. Time of 
completion for all three drawings was recorded in minutes. Redirection was recorded as the 
number of times the researcher had to repeat the directions and/or the number of times the 
participant displayed verbalizations or behaviors that were incongruent with the task. Fine 
motors skills, determined by the participant’s ability to make small and/or detailed marks on the 
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page, were recorded. Gross motors skills, determined by the participant’s ability to make large 
and/or concise marks on the page, were also recorded. The researcher also recorded whether the 
participant needed to use grip assistance (in this case, foam tubes on markers) when holding the 
markers. 
Data collection. Data collection began in January 2020 and ended in March 2020. Data 
and documents were collected and stored in both physical/hard-copy format and on a password-
protected computer. Physical copies of consent forms, FSA drawings (three sheets of paper), 
FSA Rating Manual 2nd Edition, the Face Stimulus Assessment (FSA) participant inquiry form, 
and the additional FSA observation form were stored behind two locks in the Principal 
Investigator office on the main hospital campus. 
Collected study data were stored on the hospital server with two password-protected 
Excel spreadsheets. One Excel spreadsheet contained personal health information (PHI) and 
personally identifiable information (PII). The second Excel spreadsheet held collected study 
variables. The two spreadsheets were linked by a study ID number. After the results of the study 
are presented and/or published, the Excel spreadsheets containing PHI and PII were destroyed. 
Participants in the study had all identifiers removed from all documents except the consent forms 
and were given a unique identification code to eliminate a breach of confidentiality after the 
completion of the study. Any presentations or publications of the study will exclude all 
identifiers. 
Physical copies of the FSA assessment and FSA Rating Manual 2nd Edition were rated by 
HIPAA-compliant art-therapy professionals. No identifying information was shared with the 
raters. Raters were also not told what population the FSAs were conducted on, nor were they told 
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the participants’ age. The purpose of presenting only the FSA drawings to the raters was to 
reduce bias that could have swayed scores on the FEATS. 
When the study commenced, all study documents were returned to the participant. 
Data Analysis 
The data collected from the categorical 0–5 Likert-type scales were organized into tables 
and observation forms were described through a narrative format. 
Risk and Benefit Analysis 
There were minimal risks associated with this study. Potential risk factors included the 
possible loss of confidentiality and risk of being uncomfortable answering questions on the 
participant inquiry form. To minimize the potential risk of loss of confidentiality, each 
participant was provided a unique ID number that was used for all study documents, and names 
were not connected to identifying information collected such as age range, gender, and dementia 
stage diagnosis. Participants were permitted to skip any questions in the FSA participant inquiry 
form that they felt uncomfortable answering. There was no expectation among participants of 
immediate or long-term benefits from participating in the study. However, it is hoped 
participation in the study will aid in advancing research for the FSA and the field of art therapy. 
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CHAPTER IV  
RESULTS 
The study anticipated six participants, but only one participant was recruited in the four-
week time slot for FSA data collection. Due to the COVID-19 pandemic, recruitment of 
participants was reduced to three weeks to meet social-distancing mandates. The inclusion and 
exclusion criteria restricted potential participants due to a limited number of individuals with a 
diagnosis of early-stage dementia. This section will report the data collected on the participant’s 
demographics and diagnosis, the FSA’s modified FEATS results, the FSA participant inquiry 
form, and the additional FSA observation form. 
This study assessed whether older adults diagnosed with early-stage dementia had the 
ability to finish the FSA, whether the FSA would need to be adjusted to be used with this 
population, and whether there were any consistencies in FEATS variable scores. Generalizing 
the results and recommendations with regard to the appropriateness of the FSA for participants 
with an early-stage dementia diagnosis is not possible due to the case-study format. However, the 
one participant (Participant 1) was able to complete the FSA and research protocols. 
Instead of rating only the second stimulus drawing, all three drawings were rated in 
Participant 1’s FSA. The purpose of rating all three was to observe the potential for changes to 
the average score as the FSA stimulus drawings progressed with less structure. This decision was 
made to increase the amount of data reviewed. Additionally, scoring all three drawing for 
individuals with a dementia diagnoses may provide a wider variety of understanding of client 
functioning over time. 
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Participant Demographics 
Participant 1 was an 88-year old non-Hispanic/Latina female. Her diagnosis of early-stage 
dementia by a geriatrician was based on the following examinations: physical exam, functional 
screening, interview with patient and caregivers, neuropsychological testing, Geriatric 
Depression Scale (GDS) test, and Geriatric Anxiety Disorder 7 (GAD-7) test. Geriatrician 
interviews included self-reports and participant caregiver reports that noted the following 
concerns: decreased problem-solving skills, decreased self-care skills, wanting to stay home, 
short-term memory loss, difficulty with sequencing and numbers, behavior changes (for 
example, being in a “pissy” mood), depressed mood, difficulty with finding words, and memory 
lapses. 
FSA Modified FEATS 
The FSA modified FEATS was rated by three practicing registered board-certified art 
therapists. One rater was able to meet in person to rate the FSA. The other two met via Zoom due 
to COVID-19 social-distancing regulations and safety precautions during the time of data 
collection. Deidentified FSA drawings were shared via screen share on Zoom and rater results 
were shared on a cloud-based storage software that requires two-step verification for entry. 
Tables 1–3 organized the raters’ scores from all three stimulus drawings and include the average 
of each score. 
Table 1 shows the FEATS variable scores for drawing 1. Stimulus drawing 1 consisted of 
the pre-drawn outline of the head, shoulders, eyes, nose, mouth, ears, and eyebrows. Figure 1 
shows FSA drawing 1 completed by Participant 1. 
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Table 1  
Drawing 1 FSA modified FEATS scores 
FEATS Variable Rater 1 Rater 2 Rater 3 Average 
Prominence of Color 2 2.5 2 2.2 
Color Fit 5 5 5 5 
Implied Energy 2.5 2.5 3 2.7 
Logic 4 5 4.5 4.5 
Realism 3.5 4 3.5 3.7 
Developmental Level 4 4 4 4 
Details of Objects & Environment 3 2 3 2.7 
Line Quality 3 3 3 3 
Perseveration 4 4 4.5 4.2 
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Figure 1. FSA drawing 1 by Participant 1. 
Table 2 shows the FEATS variable scores for drawing 2 in the FSA. In the FSA manual, 
drawing 2 is the only drawing rated using the modified FEATS because it provides the least 
amount of stimulus imagery. Figure 2 shows FSA drawing 2 completed by Participant 1. 
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Table 2   
Drawing 2 FSA modified FEATS scores 
FEATS Variable Rater 1 Rater 2 Rater 3 Average 
Prominence of Color 2 2 1 1.7 
Color Fit 4 5 3.5 4.2 
Implied Energy 3 3 3 3 
Logic 4.5 4.5 4.5 4.5 
Realism 3.5 3 3.5 3.3 
Developmental Level 4 3.5 3 3.5 
Details of Objects & Environment 3 3 3.5 3.2 
Line Quality 2 2 3 2.3 
Perseveration 3 4.5 4 3.8 
Running head: FSA WITH EARLY-STAGE DEMENTIA  34 
 
Figure 2. FSA drawing 2 by Participant 1. 
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Table 3 
Drawing 3 FSA modified FEATS scores 
FEATS Variable Rater 1 Rater 2 Rater 3 Average 
Prominence of Color 1 1 1 1 
Color Fit 4 5 3.5 4.2 
Implied Energy 3 3 3 3 
Logic 5 5 4.5 4.8 
Realism 4 3.5 2.5 3.3 
Developmental Level 3 2.5 3 2.8 
Details of Objects & Environment 2 2.5 4 2.8 
Line Quality 2.5 4 3.5 3.3 
Perseveration 4 5 4.5 4.5 
Table 3 shows FEATS variable scores collected by the three raters for drawing 3. In the 
FSA, drawing 3 is presented as a blank sheet of paper. As stated, the third drawing is given to 
participants to see if they have the ability to draw or attempt to draw a face after the two previous 
stimulus drawings. Figure 3 shows FSA drawing 3 completed by Participant 1. 
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Figure 3. FSA drawing 3 by Participant 1. 
Table 4 shows the average scores of all three drawings. 
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Table 4 
Average FEATS scores from drawing 1, drawing 2, and drawing 3 
FEATS Variable Drawing 1 Drawing 2 Drawing 3 
Prominence of Color 2.2 1.7 1 
Color Fit 5 4.2 4.2 
Implied Energy 2.7 3 3 
Logic 4.5 4.5 4.8 
Realism 3.7 3.3 3.3 
Developmental Level 4 3.5 2.8 
Details of Objects & Environment 2.7 3.2 2.8 
Line Quality 3 2.3 3.3 
Perseveration 4.2 3.8 4.5 
Interrater Reliability 
A reliability analysis of the rater’s scores was carried out on the FEATS variables 
gathered from Participant 1’s FSA. Interrater reliability was high with all three raters. 
Cronbach’s alpha showed the interrater reliability to be acceptable at α = .962. To further support 
the claim of acceptable consistency of FEATS variable scores between raters, Table 5 shows the 
inter-item correlation of each rater to be at least .869. A significant relationship was found 
between rater scores and outcome of the FEATS variable F(1,8) = 25.98, p = .000. Descriptive 
statistics found a mean value of 10.61 with a standard deviation of 2.88, (M=10.61, SD=2.88), 
with a 95% correlational index (CI) of [.709, .972]. 
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Table 5    
Inter-item Correlation Matrix  
 Rater 1 Rater 2 Rater 3 
Rater 1 1.000 .869 .966 
Rater 2 .869 1.000 .878 
Rater 3 .966 .878 1.000 
FSA Participant Inquiry Form 
The FSA participant inquiry form prompts the researcher to ask designed questions about 
each drawing after it has been completed. 
Drawing 1. This drawing is shown in Figure 1. When Participant 1 was asked how 
important it was for her to color inside the lines, she replied, “I didn’t pay any attention.” When 
asked to talk about the colors used for the face, she stated that she couldn’t find any color that 
was “acceptable” for flesh tones, so she just ignored it. When asked to elaborate on the added 
elements of the drawing, she stated that the drawing was of a Japanese geisha and that the pin on 
her head was “a sign of the house where she lives.” When asked if the drawing was of a person 
she knew, she stated, “Nope, I just made her up.” She said she would title the drawing Obi, 
which is a sash/garment that geisha’s wear. When asked if there was anything else she would 
like to add, she said, “I could make up lots of stories about the image, she smiles a lot.” 
Drawing 2. This drawing is shown in Figure 2. When Participant 1 was asked to talk 
about the colors used for the face, she stated, “I highlighted everything but the face color—it 
wasn’t important to me. This is Lucy with a runny nose. Her eyes are cockeyed, and her mouth is 
a little off.” The researcher asked about other elements in the drawing to gain insight into the 
nose to determine if it was a runny nose or nosebleed. Participant 1 stated, “She has sinus 
problems. I would have drawn a Kleenex if hands were there. I would have her in mind for 
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casting a show for Lucy.” When the researcher asked if she knew the person in the drawing, she 
elaborated that this was a drawing of Lucy from the “Charlie Brown” cartoon. She said she 
would title the drawing Rats, which is a common phrase said in the cartoon. Finally, the 
researcher asked whether the participant would like to add any additional comments. Participant 
1 stated, “I like her…and that’s it.” 
Drawing 3. This drawing is shown in Figure 3. When Participant 1 was asked to talk 
about the colors used for the face, she stated, “I started to draw a clown, but it didn’t look right. 
So, I gave her blonde hair and a purple bow. Her ears are hardly showing because of her blonde 
hair. That is how it turned out. I messed up her mouth, but maybe she’s someone yelling out.” 
When asked about the additional elements in the drawing, such as the purple bow, Participant 1 
stated, “the purple bow is for Northwestern University.” Participant 1 stated this drawing was 
“pure imagination.” When asked what she would title the drawing, she said, “I might title it, My 
Sweet Great-Granddaughter.” When asked if there was anything more she would like to add, she 
said, “She’s a real sweetheart with a big mouth, wide eyes, and a bow in her hair.” 
Additional FSA Observation Form  
The additional FSA observation form (Appendix C) recorded data relating to the 
following: completion time for three stimulus drawings, participant capability, redirection 
prompts, observations of motor functioning, and observations of any other notable verbalizations 
or behaviors during the assessment. 
Completion. The participant was able to complete the FSA within the 60-minute time 
frame. Participant 1 completed the FSA in 24 minutes. 
Redirection. Participant 1 did not need redirection and did not need to have directions 
repeated during each drawing. 
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Motor functioning. Participant 1 was able to hold the markers and did not need grip 
assistance (foam tubes on markers). However, Participant 1 did need assistance with taking the 
caps off of the markers. Regarding fine motor skills, the participant was able to make small 
and/or detailed marks on the page. As for gross motor functioning, Participant 1 was able to 
make large and/or concise marks on the page. No additional motor functioning observations were 
noted. 
Notable verbalizations and behaviors. Verbalizations made by Participant 1 while the 
FSA was administered, and the participant inquiry form was filled out did match what was drawn 
on all three stimulus drawings. Drawing 2 elicited changes in behavior as Participant 1 became 
frustrated when drawing the hair. Participant 1 also laughed and verbalized, “Well you’re no fun, 
are ya?” when presented with the blank page for drawing 3. No additional verbalizations and/or 
behaviors were noted. 
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CHAPTER V  
DISCUSSION 
Self-portraits and depictions of others have existed in human culture since the 
development of the conscious self (National Geographic, 2018), coinciding with facial and 
emotional recognition. This is exemplified by works of art ranging from 52,000-year-old cave 
drawings (National Geographic, 2018) depicting human figures (the first known signs of human 
creativity), to Egyptian tomb paintings, to portraits by artistic greats like Rembrandt and Frida 
Kahlo, to the modern-day selfie.  
Betts (2003) describes elements of physical appearance and facial features as “powerful 
determinants of how one perceives oneself and others” (p. 78). Betts was intentional in her 
reasoning for using a face as the stimulus image in her art-based assessment due to its 
relationship to cognitive functioning. There are benefits to using a face as a stimulus image 
rather than having subjects draw a clock or copy shapes because images of faces elicit strong 
reactions and motivations. 
Humans have the instinctual ability to recognize faces and read emotions from a very 
early age. Newborns who are just 8 hours old can recognize faces (Walton & Bower, 1993) and 
children can perceptually encode faces to the same degree as adults by age 5 (McKone, Crookes, 
Jeffery, & Dilks, 2012). Betts (2003) found that the individuals she worked with who had 
communication difficulties responded best to a stimulus image of a face and could project their 
own ideas onto the page—even if it was just scribbling. Additionally, the face stimulus could 
reveal information and focus on their strengths instead of their disabilities (Betts, 2003). 
The FSA has the ability to fill the gaps of other traditional methods of cognitive 
assessment for dementia such as the MMSE, MoCA, and CDT due to its use of the FEATS. 
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Although there are drawing components to the MoCA and the CDT, they do not specifically 
assess how drawings are done, but rather whether they are completed with specified accuracy. 
The modified FEATS supersedes scoring of the CDT because it evaluates nine specific variables 
that pertain to how something is drawn rather than whether a subject had the ability to complete 
the drawing. With more research on the FEATS with individuals with a dementia diagnosis, 
there is the potential of identifying specific graphic indicators that align with the various stages 
of the disease. The FEATS may also have the ability to track the progression of the disease 
through its potential use of graphic indicators of dementia and observational changes in these 
elements as the brain deteriorates. Stewart (2004) found that the FEATS was effective when used 
with individuals diagnosed with dementia—specifically for tracking progression, regression, 
graphic indicators, and general problem solving and cognitive ability. Additionally, the FSA and 
the FEATS can potentially be used with individuals who experience delays or challenges with 
literacy or verbal articulation. Gantt (2016) stated: 
Perhaps the greatest advantage (when using the FEATS) is that information is captured 
even if a person has trouble with traditional verbal interviews. What may be most 
apparent are psychotic symptoms and organic disorders. In this regard, the FEATS may 
reveal more than the Mini‐Mental Status Exam (MMSE) (p. 573). 
Due to language impairments in the early stage of AD (Ferris & Farlow, 2013) and to 
difficulty producing and/or comprehending language with FTD (Fymat, 2018), a person might be 
able to cognitively perform better on a stimulus image drawing than recall- or language-based 
assessments like the MMSE and MoCA. 
Even so, there is limited accuracy on interrater reliability with clinicians using the CDT 
(Price et al., 2011). According to Price et al. (2011), reliability should be a primary consideration 
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when employing cognitive assessments; without this data, it is difficult to accurately follow 
longitudinal changes in a patient’s decline. In the case of this study, the FSA and its use of the 
FEATS had statistically significant reliable outcomes in scores from all three raters, with α = 
.962. This supports the FSA’s potential to accurately follow longitudinal changes in patients with 
dementia. 
Due to the lack of participants in this study, results cannot be easily generalized to larger 
populations; therefore, it is difficult to determine whether the FSA could be effectively used with 
individuals diagnosed with early-stage dementia. However, Participant 1 successfully completed 
the FSA in the allotted 60-minute time frame, completed the participant inquiry form, and 
demonstrated limited difficulty with the variables addressed on the additional FSA observation 
form. This shows promise in the FSA’s ability to help practitioners track the progression of 
dementia in their patients. 
Modified FEATS Analysis 
Color fit, logic, and perseveration. The variables with highest average scores for all 
three drawings were color fit, logic, and perseveration. Color fit assesses whether colors are 
appropriate to what was drawn, logic shows impairments in abstract thinking, and perseveration 
shows unawareness of repetition in elements or line quality (Gantt & Tabone, 1998). Research 
states that perseveration and impairments in abstract thinking are consistent with symptoms of a 
dementia diagnosis (Gantt & Tabone, 1998; Kahn-Denis, 1997; University of California, San 
Francisco: Memory and Aging Center [UCSF], 2020). However, there are no specific criteria on 
how this presents in each stage. 
There are a few inconsistencies when analyzing color fit scores and symptomology of 
dementia, specifically with regard to visuospatial functioning in an early-stage dementia 
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diagnosis and difficulty in deciphering color (Quental et al., 2013). Participant 1’s color fit score 
was highly rated by all three raters; however, Participant 1 stated in the participant inquiry form 
that there was no marker she found to be “appropriate” for skin tone even though Participant 1 
was presented with a pack of multicultural markers. 
Participant 1 scored high on color fit, logic, and perseveration, demonstrating that there 
were few concrete indicators present for those variables. However, as a dementia diagnosis 
progresses, perseveration could present itself in drawings as the repetition of shapes and lines 
that are not intentional as well as in excessive repetitive pressure applied to the page with the 
markers resulting in the marker bleeding through the page and/or holes in the page. These 
graphic indications would be consistent with repetitive and compulsive symptoms of a middle-
stage diagnosis (Alzheimer’s Association, 2018b; Reisberg et al., 1982). Graphic indicators of 
logic may present as drawing imagery not consistent with the stimulus of a face or using drawing 
3 to draw something unrelated to a face. This would be representative of a further decline in 
abstract thinking indicative of the progression of an AD diagnosis (Quental et al., 2013). 
Specifically, for progression of an AD diagnosis, graphic indications of decline could include the 
use of colors that are not considered appropriate for what is being drawn. For example, an 
individual might use purple or green to color in the face or use only one color to complete the 
whole drawing. This can be a graphic indicator in AD symptomology of not being able to 
discriminate from different colors (Quental et al., 2013). 
Prominence of color. The component with the lowest average score for all three 
drawings was prominence of color. Out of all three drawings, the only elements that were fully 
colored in were the lips on drawing 1 (see Figure 1) and the pupils on drawings 1 and 2 (see 
Figures 1 and 2). The majority of all three drawings consist of single drawn lines, with no shapes 
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or spaces fully colored in. This finding is consistent with the literature and matches common 
characteristics of artwork by those diagnosed with dementia such as the use of a restricted color 
palette (Mendez, 2004; Palmiero et al., 2012; Safar & Press, 2011). Individuals who have 
symptoms of depression tend to use less color in their artwork as it is thought to be directly 
related to affect; this is also consistent with the literature (Gantt & Tabone, 1998). The lack of 
filled-in shapes and spaces in all three drawings could be indicative of the common 
characteristics in dementia artwork and depressive moods associated with Participant 1’s 
diagnosis. 
Developmental level, details of objects and environment, and realism. Participant 1’s 
average score for drawing 3 in developmental level was 2.8 (see Table 4). Upon observation, 
Participant 1’s drawing could be consistent with Lowenfeld’s preschematic stage, but cusping 
the schematic stage. Drawings of human figures in the late preschematic stage include elements 
of hair and other details. In addition, body parts may be distorted or omitted, the human figure is 
looking at the viewer, and objects seem to float in the page (Lowenfeld & Brittain, 1987). 
Drawings in the schematic stage show baselines or representations of the ground or environment. 
Also, proportions depend on emotional values, arms and legs show volume and are correctly 
placed, there is an organization of 2D objects, and objects are bold and flat. Finally, subjective 
representation of space is common, as with X-ray drawings (Lowenfeld & Brittain, 1987). (An 
X-ray drawing is one in which both the outside and the inside of an object is visible (Lowenfeld 
& Brittain, 1987)—i.e., in Figure 3, the outline of the head can be seen under the outline of the 
hair.) In drawing 3 (see Figure 3), preschematic representation is found in the following 
components: the detail in the hair, eyelashes, and bow; the omission of the neck and shoulders; 
the figure appearing to float in space; and the fact that the figure is looking at the viewer. 
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Representation of the schematic stage can also be seen through the image’s boldness, flatness, 
and subjective space representation (specifically, in the way the lines that represent the sides of 
the face are seen underneath the hair or with an x-ray drawing style). However, it does not meet 
all the requirements to be classified solely as a schematic drawing because the image has no 
baselines or indications of the ground or environment.  
It is important to note that Lowenfeld’s artistic developmental levels were designed to 
assess the development of children and adolescents; however, when most adults are asked to 
draw, they typically fall in the pseudo-naturalistic stage. This is because the age of 12 marks the 
end of artistic development (Lowenfeld & Brittain, 1987). Participant 1’s artistic developmental 
level is below the average adult. This could be indicative of either her dementia diagnosis and 
the deterioration of her brain or a failure to develop the skills needed to draw at the pseudo-
naturalistic stage during the course of her lifetime. 
Although Participant 1 did not include an environment in all three drawings, there are 
additional details added to the faces. Drawing 2 (see Figure 2) has the highest average score with 
the most additional details added. In drawing 3 (see Figure 3), Participant 1 was capable of 
drawing a face; however, the shoulders and neck were omitted. According to Gantt and Tabone 
(1998) omission of objects and the environment is suggestive not only of depression but also of 
organic mental disorders such as dementia—both of which line up with Participant 1’s 
symptomology. The lack of environment in all three drawings could be indicative of the decline 
in visuospatial functioning and awareness common with an AD diagnosis (Quental et al., 2013). 
Looking to future research, conducting a baseline FSA assessment before an individual 
develops and is diagnosed with dementia may make this variable more effective. Additionally, 
keeping in mind that Lowenfeld developed the five stages of artistic development based on the 
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artistic developmental levels of children, it might be possible to develop a distinct body of FSA 
artwork to determine whether there are consistent developmental changes in drawings as the 
dementia disease progresses. Essentially, it may be possible to replace this FEATS 
developmental variable with one more fitting for this population. Until there is an artistic 
developmental level that tailors more to this specific population, the use of this variable in rating 
the FSA might not be necessary.  
Realism assesses how realistic and representational the elements in a drawing are. Gantt 
and Tabone (1998) state that most individuals with an AD diagnosis draw unrecognizable 
pictures. Because Participant 1’s drawings are recognizable, this variable could potentially be 
valuable in tracking the progression of the disease. Participant 1’s drawings did not appear to 
have any shading, which is a key element of realism, but they were still recognizable as faces. As 
a dementia diagnosis progresses, realism will decline as drawings begin to look flat and 
fragmented (Gantt & Tabone, 1998), which could be directly correlated with the decline in 
spatial orientation consistent with a middle- to late-stage dementia diagnosis (Reisberg et al., 
1982). 
Line quality and implied energy. Line quality corresponds with how much control an 
individual has while creating the drawing. In drawing 3 (see Figure 4), the black circles show 
where lines are disconnected—that is, where a gap exists between where a shape started and 
where it finished. Broken lines, disconnections between lines, and unclosed shapes can be 
defined as organic gaps, as they appear in drawings made by individuals with organic disorders 
such as dementia (Gantt & Tabone, 1998). Line quality could be a direct correlation with motor 
functioning, as motor functioning declines with a dementia diagnosis (Alzheimer’s Association, 
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2018a; Alzheimer’s Association, 2018b; Denis-Kahn, 1997; Fymat, 2018; Reisberg et al., 1982). 
Graphic indicators of decline could present in lines as fragmentation, non-fluidity, and rigidness. 
 
Figure 4. FSA drawing 3 by Participant 1 showing organic gaps in lines and shapes. 
Implied energy attempts to rate the amount of effort and energy the individual expended 
to create the drawing. This is determined by pressure, movement, and level of detail. Participant 
1 scored a 2.7 for drawing 1, a 3 for drawing 2, and a 3 for drawing 3. A rating of 3 on the Likert 
scale is considered an average amount of energy (Betts, 2013b). Participant 1 showed an increase 
in implied energy over the progression of the assessment as the stimulus drawings became more 
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independent. This could be indicative of needing to exert more energy as the stimulus images 
became less structured. 
Identifying specific graphic indicators for each variable present in each stage of dementia 
will require further research on larger scales. The graphic indicators presented here are only 
predictions of what might correlate with symptoms of each stage and type of dementia presented 
in the literature. Graphic indicators would not be used as a way to diagnose dementia, but instead 
could help art therapists and other practitioners pinpoint specific graphic elements as symptom 
equivalents. Graphic indicators might also provide additional information about an individual’s 
cognitive performance because these indicators do not rely on verbal or language processing. Not 
only that, but art therapists could use these identified graphic indicators in artwork apart from the 
FSA to further assess and evaluate patients in geriatric facilities to better tailor art interventions 
and directives to best suit their needs. 
Additional FEATS scales that could be used with this population might include variables 
like space, integration, and person. Space allows for an analysis of an individual’s ability to fill 
the drawing. It would be interesting to see whether in drawing 3, the space used to draw the face 
is consistent in size with the previous stimulus drawings or if the face is drawn smaller or larger. 
Integration allows for the analysis of abstract thinking in organization, spatial relationships of 
elements in the artwork, disintegration, and fragmentation, which are distributed in dementia 
(Gantt & Tabone, 1998). Finally, drawing a full person may be beneficial because according to 
Gantt and Tabone (1998), “misplaced body parts, shrunken arms and legs, and distorted parts 
other than head or extremities” (p. 41) are indicators of brain damage and organic deterioration. 
This can be seen in drawing 3 (see Figure 3) with the omission of the neck and shoulders. 
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Participant Inquiry Form Analysis 
Participant 1 was able to answer all questions provided in the participant inquiry form. 
However, two answers required clarification from Participant 1. The first related to the red mark 
below the nose in drawing 2 (see Figure 2). Participant 1 clarified it as a nosebleed and 
explained that the person in the drawing had sinus issues. The second related to drawing 3. 
Participant 1 first stated that the person in the drawing came from her imagination; however, she 
titled the drawing My Sweet Great Granddaughter. Participant 1 stated that she was unable to 
recall her great-granddaughter’s name. This could be indicative of short-term memory loss 
associated with an early-stage dementia diagnosis. However, it could also be that she decided the 
drawing looked like her great-granddaughter during that time frame and did not elaborate further. 
This additional data form is beneficial for understanding and providing context for the 
FSA drawings. Currently, the participant inquiry form is not used as a tool to assist in rating the 
FSA drawings. It might be beneficial to see answers to the participant inquiry form when rating 
the logic variable (e.g. when specifically looking at bizarre objects in the drawings) for 
clarification and context. 
Betts (2013b) provides an FSA systematic observation guideline form if an individual has 
difficulty with verbal communication and is unable to answer questions for the participant 
inquiry form. 
Additional FSA Observation Form Analysis 
According to information entered into the additional FSA observation form, Participant 1 
did not need redirection or directions of the assessment reiterated. She was able to hold the 
markers without foam grips and demonstrated mastery in fine and gross motor skills to render 
the images. Finally, her verbalizations during the assessment matched what was being drawn. 
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The use of this form would support tracking disease progression because it is likely that 
there could be a decline in visuospatial functioning (i.e. fine and gross motor skills) and short-
term memory (requiring redirection and repetition of directions) as well as changes in mood (that 
is, notable changes in behavior and verbalizations) (Alzheimer’s Association, 2018a; 2018b; 
Denis-Kahn (1997) Fymat, 2018; Reisberg et al., 1982). Additional research is needed to check 
the form’s reliability with all stages of dementia. 
Limitations 
A key limitation to the FSA and the modified FEATS is that they limit the assessment’s 
transferability to other professions. Primarily because of the language and knowledge used to 
rate the FEATS, doctors, geriatricians, and researchers without a background in formal elements 
or formal analysis may yield contrasting results on the Likert-type scales. 
When looking critically at the FEATS and its ability to rate imagery based on DSM III 
criteria, many variables from Participant 1’s FSA drawing are consistent. However, as the DSM 
continues to evolve, it is necessary to reevaluate and update the FEATS to align with current 
diagnostic materials. 
Another limitation is the lack of current research on the FSA and art therapy–based 
assessments of dementia populations. Developing a body of FSA artwork with older adults 
diagnosed with early-, middle-, and late-stage dementia would be beneficial to the validity and 
reliability of this assessment as a tool to track the progression of dementia. This would provide 
more specific data on graphic elements or indicators to look for with those diagnosed with 
dementia. Additionally, it would provide insight into the modifications needed to the FEATS 
manual to capture developmental level and color use with older adults diagnosed with dementia. 
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CHAPTER VI  
CONCLUSIONS AND RECOMMENDATIONS 
This study is the tip of the iceberg with regard to how the FSA could assess and track the 
progression of dementia. Dementia is a complex and diverse disease that manifests in many 
different ways and with an array of symptoms. It would be best addressed using a 
multidisciplinary approach that affords providers with a wide variety of perspectives on the 
symptomology and progression of the illness. An integrated approach to research on the 
assessment, treatment, and progression of dementia could provide a deeper understanding of the 
diagnosis and better treatment outcomes. 
Although the study did not recruit six participants, the case study yielded rich information 
pertaining to the potential for the FSA to be used with those diagnosed with dementia. According 
to the data collected from this case study, Participant 1 was able to successfully complete the 
FSA and FSA participant inquiry form. A review of the literature resulted in valuable and 
validating data regarding graphic indicators and dementia, as well as data on the potential for the 
FSA to be used as an assessment to track the progression of dementia. The FSA additional 
observation form requires additional study in middle- to late-stage diagnoses to determine 
whether it is a tool that can be applicable for tracking. 
Recommendations 
Participant 1’s scores from all three drawings show that even with an early-stage 
dementia diagnosis, the FSA could be a good baseline assessment for tracking progression. 
However, to improve the validity and reliability of this assessment with this population, a few 
suggestions for further research are presented here. 
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One is to develop in larger-scale studies with the FSA and those diagnosed with 
dementia, as well as normative studies with older adults not diagnosed with dementia. Another is 
to design progression studies with the use of the FSA with individuals as they progress through a 
dementia diagnosis, including the use of the FSA with specific dementia types, to see if specific 
graphic indicators are present with different dementia diagnoses. A third is to develop 
comparison studies on the use of the FSA compared to the MMSE, MoCA, and CDT. Research 
may benefit from seeing correlational studies of the MMSE and the FSA because of language 
impairments in early-stage dementia (Ferris & Farlow, 2013); it would be interesting to see if 
individuals perform better on the FSA or the MMSE. The development of research for the FSA 
with individuals diagnosed with dementia could even provide a body of artwork to cultivate an 
artistic developmental level system that is more effective than Lowenfeld’s developmental 
stages. 
In conclusion, there is opportunity for valuable research to be conducted on the FSA and 
the modified FEATS as a tool for tracking progression of dementia. There is also ample 
opportunity to enhance the definition of common graphic indicators and elements of dementia 
artwork on a much larger scale. It is important to note that although this study suggests that the 
FSA is deemed suitable for further research with dementia patients, the FSA would not be used 
as a tool for diagnosing dementia. Rather, it would be used to help differentiate symptoms that 
other cognitive assessments may overlook because its foundations are rooted in stimulus imagery 
and not language. 
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APPENDIX A 
IU INFORMED CONSENT 
INDIANA UNIVERSITY INFORMED CONSENT STATEMENT FOR RESEARCH 
 
The use of the Face Stimulus Assessment (FSA) with Early-Stage Dementia 
IUPUI 2001848206 
 
ABOUT THIS RESEARCH 
You are being asked to participate in an art therapy-based research study. Art therapists do 
research to answer important questions which might help change or improve the way we do 
things in the future. 
 
This consent form will give you information about the study to help you decide whether you 
want to participate. Please read this form, and ask any questions you have, before agreeing to 
be in the study. 
 
TAKING PART IN THIS STUDY IS VOLUNTARY 
Research participation is voluntary, and you may withdraw from the study at any time. Deciding 
to participate or to leave the study will not result in any penalty or loss of benefits to which you 
are entitled and will not affect your relationship with Ascension St. Vincent Center for Healthy 
Aging or Indiana University. 
 
WHY IS THIS STUDY BEING DONE? 
The purpose of this study is to find out if an art-based cognitive assessment called the Face 
Stimulus Assessment (FSA) can be used to identify symptoms of early-stage dementia 
 
You were selected as a possible participant because you are currently a patient at Ascension St. 
Vincent’s Center for Health Aging and have a diagnosis of early-stage dementia. 
 
The study is being conducted by Ashleigh Mower, art therapy graduate student at Herron 
School of Art and Design at IUPUI. Eileen Misluk, Assistant Professor at Herron School of Art and 
Design, IUPUI in the Master of Art in Art Therapy Program will oversee the research study. 
 
HOW MANY PEOPLE WILL TAKE PART? 
If you agree to participate, you will be one of six patients at Ascension St. Vincent’s Center for 
Healthy Aging in this study. 
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WHAT WILL HAPPEN DURING THE STUDY? 
If you agree to be in the study, you will do the following things: 
 
• Meet to review the informed consent forms and be given the opportunity to ask any questions 
or concerns they may have about participating in the study. 
• Complete the Face Stimulus Assessment and the Face Stimulus Participant Inquiry Form within 
the 90-minute allotted time. 
• All sessions will be held in a private room at the Center for Healthy Aging. 
• The study will begin in January and commence in April. 
 
WHAT ARE THE RISKS OF TAKING PART IN THE STUDY? 
There are minimal risks associated with this study. A potential risk of being in the study would 
be a risk of possible loss of confidentiality. Additionally, there is a potential risk of being 
uncomfortable answering questions in the inquiry form. 
 
To minimize the potential risk of loss of confidentiality, each participant will be provided a 
unique ID number that will be used for all study documents and names will not be connected to 
identifying information collected such as age range, gender, and dementia stage diagnosis. 
Participants are able to skip any questions in the inquiry form that they are uncomfortable 
answering. 
 
Participants will be required to have a Legally Authorized Representative (LAR) present for 
consent review. 
 
WHAT ARE THE POTENTIAL BENEFITS OF TAKING PART IN THE STUDY? 
We don’t expect you to receive any benefit from taking part in this study, but we hope to learn 
things which will help art therapists in the future such as; advancing research for the Face 
Stimulus Assessment, and the field of art therapy. 
 
WILL I RECEIVE MY RESULTS? 
We may learn things about you from the study activities which could be important to your 
health or to your treatment. If this happens, you can decide whether you want this 
information to be provided to you. If you decide that you want this information, you may 
need to meet with professionals with expertise to help you learn more about your research 
results. The study team/study will not cover the costs of any follow-up consultations or 
actions. Please initial one of the following options: 
______ Yes, I want to be provided with this information. 
______ No, I do NOT want to be provided with this information. 
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Assessments will be kept in the possession of the researcher/ research committee until the 
commence of the study. Once the study has commenced you will have the option to be given 
the physical copies of your assessment. 
 
HOW WILL MY INFORMATION BE PROTECTED? 
Efforts will be made to keep your personal information confidential. We cannot guarantee 
absolute confidentiality. Your personal information may be disclosed if required by law. No 
information which could identify you will be shared in publications about this study nor will 
databases in which results may be stored. The researcher will maintain confidentiality of the 
participants by assigning unique identification numbers on the data collection. A Digital copy of 
your Face Stimulus Assessment will be held on a password protected computer and the 
hardcopies of the images will be secured by the art therapy program for educational materials. 
 
Organizations that may inspect and/or copy your research records for quality assurance and 
data analysis include groups such as the study investigator and her research associates, the 
Indiana University Institutional Review Board or its designees, Ascension St. Vincent 
Institutional Review Board or its designees, the study sponsor Herron School of Art and Design, 
and Indiana University Purdue University of Indianapolis faculty. 
 
WILL I BE PAID FOR PARTICIPATION? 
You will not be paid for participating in this study. 
 
WILL IT COST ME ANYTHING TO PARTICIPATE? 
There is no cost to you for taking part in this study. 
 
WHAT FINANCIAL INTEREST DOES THE RESEARCHER HAVE? 
There is no financial interest to the researcher. This study is being completed for a master’s 
level thesis. 
 
WHO SHOULD I CALL WITH QUESTIONS OR PROBLEMS? 
For questions about the study contact the researcher, Ashleigh Mower, at 317-529-4842 and/or 
amower@iu.edu and/or Eileen Misluk at 317-278-9460 or emisluk@iupui.edu 
 
For questions about your rights as a research participant, to discuss problems, complaints, or 
concerns about a research study, or to obtain information or to offer input, please contact the 
IU Human Subjects Office at 800-696-2949 or at irb@iu.edu. 
 
WILL I BE CONTACTED ABOUT RESEARCH IN THE FUTURE? 
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Information collected from you for this research may be used for future research studies or 
shared with other researchers for future research. If this happens, information which could 
identify you will be removed before any information is shared. Since identifying information will 
be removed, we cannot ask for your additional consent. 
 
 
CAN I WITHDRAW FROM THE STUDY? 
If you decide to participate in this study, you can change your mind and decide to leave the 
study at any time in the future. The study team will help you withdraw from the study safely. If 
you decide to withdraw, tell the researcher and you will be removed from future survey 
collection procedures. 
 
CONSENT 
In consideration of all of the above, I give my consent to participate in this research study. I will 
be given a copy of this informed consent document to keep for my records. I agree to take part 
in this study. 
 
Participant’s Printed Name:  
 
Participant’s Signature: Date:  
 
 
Printed Name of Consenter/LAR: 
  
 
Signature of Consenter/LAR:       Date:    
 
 
Printed Name of Student Researcher:    
 
Signature of Student Researcher: Date:  
 
 
Printed Name of Principle Investigator:    
 
Signature of Principle Investigator: Date:  
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